161 related articles for article (PubMed ID: 37350943)
1. A comparative study of gastric adenocarcinoma HER2 IHC phenotype and mass spectrometry-based quantification.
Xu B; Chen H; Zhang J; Cong Y; Ning L; Chen L; Zhang Y; Zhang Y; Song Z; Meng Y; He L; Liao WL; Lu Y; Zhao F
Front Oncol; 2023; 13():1152895. PubMed ID: 37350943
[TBL] [Abstract][Full Text] [Related]
2. Mass-spectrometry-based quantitation of Her2 in gastroesophageal tumor tissue: comparison to IHC and FISH.
Catenacci DVT; Liao WL; Zhao L; Whitcomb E; Henderson L; O'Day E; Xu P; Thyparambil S; Krizman D; Bengali K; Uzzell J; Darfler M; Cecchi F; Blackler A; Bang YJ; Hart J; Xiao SY; Lee SM; Burrows J; Hembrough T
Gastric Cancer; 2016 Oct; 19(4):1066-1079. PubMed ID: 26581548
[TBL] [Abstract][Full Text] [Related]
3. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
4. Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma.
Yoshida H; Yamamoto N; Taniguchi H; Oda I; Katai H; Kushima R; Tsuda H
Virchows Arch; 2014 Aug; 465(2):145-54. PubMed ID: 24889042
[TBL] [Abstract][Full Text] [Related]
5. Human epidermal growth factor receptor 2 amplification detection by droplet digital polymerase chain reaction in formalin-fixed paraffin-embedded breast and gastric cancer samples.
Wang X; Wu Y; Song X; Sun C; Wu C; Feng H
J Cancer Res Ther; 2017; 13(4):730-734. PubMed ID: 28901323
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a HER2 scoring system for gastric cancer: results from a validation study.
Hofmann M; Stoss O; Shi D; Büttner R; van de Vijver M; Kim W; Ochiai A; Rüschoff J; Henkel T
Histopathology; 2008 Jun; 52(7):797-805. PubMed ID: 18422971
[TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
[TBL] [Abstract][Full Text] [Related]
8. Absolute quantitation of Met using mass spectrometry for clinical application: assay precision, stability, and correlation with MET gene amplification in FFPE tumor tissue.
Catenacci DV; Liao WL; Thyparambil S; Henderson L; Xu P; Zhao L; Rambo B; Hart J; Xiao SY; Bengali K; Uzzell J; Darfler M; Krizman DB; Cecchi F; Bottaro DP; Karrison T; Veenstra TD; Hembrough T; Burrows J
PLoS One; 2014; 9(7):e100586. PubMed ID: 24983965
[TBL] [Abstract][Full Text] [Related]
9. A nCounter CNV Assay to Detect HER2 Amplification: A Correlation Study with Immunohistochemistry and In Situ Hybridization in Advanced Gastric Cancer.
Ahn S; Hong M; Van Vrancken M; Lyou YJ; Kim ST; Park SH; Kang WK; Park YS; Jung SH; Woo M; Lee J; Kim KM
Mol Diagn Ther; 2016 Aug; 20(4):375-83. PubMed ID: 27179810
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HER2 and Lauren Classification between Biopsy and Surgical Resection Samples, Primary and Metastatic Samples of Gastric Cancer.
Qiu MZ; Shi SM; Chen M; Wang J; Wu QN; Sheng H; Zhang HZ; Yun JP; Zhou ZW; Wang FH; Yang DJ; Xu RH
J Cancer; 2017; 8(17):3531-3537. PubMed ID: 29151938
[No Abstract] [Full Text] [Related]
11. Clinical Application of Multiple Reaction Monitoring-Mass Spectrometry to Human Epidermal Growth Factor Receptor 2 Measurements as a Potential Diagnostic Tool for Breast Cancer Therapy.
Do M; Kim H; Yeo I; Lee J; Park IA; Ryu HS; Kim Y
Clin Chem; 2020 Oct; 66(10):1339-1348. PubMed ID: 33001186
[TBL] [Abstract][Full Text] [Related]
12. A gene-protein assay for human epidermal growth factor receptor 2 (HER2): brightfield tricolor visualization of HER2 protein, the HER2 gene, and chromosome 17 centromere (CEN17) in formalin-fixed, paraffin-embedded breast cancer tissue sections.
Nitta H; Kelly BD; Padilla M; Wick N; Brunhoeber P; Bai I; Singh S; Ranger-Moore J; Bieniarz C; Tsuda H; Grogan TM
Diagn Pathol; 2012 May; 7():60. PubMed ID: 22647525
[TBL] [Abstract][Full Text] [Related]
13. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
[TBL] [Abstract][Full Text] [Related]
14. Human epidermal growth-factor receptor 2 overexpression in gastric carcinoma in Thai patients.
Sornmayura P; Rerkamnuaychoke B; Jinawath A; Euanorasetr C
J Med Assoc Thai; 2012 Jan; 95(1):88-95. PubMed ID: 22379747
[TBL] [Abstract][Full Text] [Related]
15. Correlation of human epidermal growth factor receptor 2 expression with clinicopathological characteristics and prognosis in gastric cancer.
He C; Bian XY; Ni XZ; Shen DP; Shen YY; Liu H; Shen ZY; Liu Q
World J Gastroenterol; 2013; 19(14):2171-8. PubMed ID: 23599643
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Next Generation Sequencing for Detecting HER2 Copy Number in Breast and Gastric Cancers.
Niu D; Li L; Yu Y; Zang W; Li Z; Zhou L; Jia L; Rao G; Gao L; Cheng G; Ji K; Lin D
Pathol Oncol Res; 2020 Oct; 26(4):2577-2585. PubMed ID: 32621174
[TBL] [Abstract][Full Text] [Related]
17. Concordance of HER2 status tested by IHC and FISH in biopsy and surgical resection specimens and comparison with clinicopathological features in gastric carcinoma.
Nergiz D; Alikanoğlu AS; Süren D; Gömceli İ; Öztürk B
Indian J Pathol Microbiol; 2022; 65(2):321-327. PubMed ID: 35435366
[TBL] [Abstract][Full Text] [Related]
18. Quantification of Human Epidermal Growth Factor Receptor 2 by Immunopeptide Enrichment and Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded and Frozen Breast Cancer Tissues.
Kennedy JJ; Whiteaker JR; Kennedy LC; Bosch DE; Lerch ML; Schoenherr RM; Zhao L; Lin C; Chowdhury S; Kilgore MR; Allison KH; Wang P; Hoofnagle AN; Baird GS; Paulovich AG
Clin Chem; 2021 Jul; 67(7):1008-1018. PubMed ID: 34136904
[TBL] [Abstract][Full Text] [Related]
19. Quantification of HER2 by Targeted Mass Spectrometry in Formalin-Fixed Paraffin-Embedded (FFPE) Breast Cancer Tissues.
Steiner C; Tille JC; Lamerz J; Kux van Geijtenbeek S; McKee TA; Venturi M; Rubbia-Brandt L; Hochstrasser D; Cutler P; Lescuyer P; Ducret A
Mol Cell Proteomics; 2015 Oct; 14(10):2786-99. PubMed ID: 26149442
[TBL] [Abstract][Full Text] [Related]
20. MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinoma.
Catenacci DV; Ang A; Liao WL; Shen J; O'Day E; Loberg RD; Cecchi F; Hembrough T; Ruzzo A; Graziano F
Cancer; 2017 May; 123(6):1061-1070. PubMed ID: 27926778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
